Introduction {#s0001}
============

Diabetic nephropathy (DN), which may be the cause of disability, is one of the severe microvascular complications of diabetes. Therefore, how to prevent the progression of DN has become a hot focus and challenge.

According to domestic and overseas researches, renal fibrosis is one of the final major pathways of DN that may cause renal failure and subsequently lead to sudden death.[@CIT0001] And the main morphological changes, associated with the loss of kidney function in diabetic kidney, include overproduction, deposition and contraction of extracellular matrix (ECM) in the glomeruli.[@CIT0001] Collagen and fibronectin are the primary matrix proteins observed.[@CIT0002] In diabetic kidney, all of these proteins are significantly increasing in mesangial cells (MCs), resulting in glomerulosclerosis.[@CIT0003]

In DN, the increased expression of transforming growth factor beta 1 (TGF-β1) has been shown to promote accumulation of ECMs such as collagens and fibronectin,[@CIT0004] apoptosis,[@CIT0005] dedifferentiation of podocytes,[@CIT0006] and epithelial--mesenchymal transition of proximal tubules,[@CIT0007] all of which are considered to facilitate renal hypertrophy and dyfunction.[@CIT0008] Extracellular signal-regulated kinase-1/2 (ERK1/2), a member of the mitogen-activated protein kinase (MAPK) family, may express in MCs in the condition of high glucose.[@CIT0009] And, researches have demonstrated that ERK1/2 may upregulate TGF-β1 expression.[@CIT0010] Also, previous studies have proven that dysregulation of matrix metalloproteinases (MMPs)/tissue inhibitors of metalloproteinases (TIMPs) is involved in the process of renal fibrosis.[@CIT0011] MMPs, an endogenous family of enzymes, are responsible for ECM degradation. MMPs and their physiological inhibitors TIMPs construct a time-and-space dependent system. It may play a crucial role during the production of renal fibrosis and its progression to remodeling.

In this study, we aimed to explore the role of TGF-β1 and the possible regulating mechanism among TGF-β1, ERK1/2, and MMPs/TIMPs *in vivo*.

Materials and methods {#s0002}
=====================

Diabetes model induction {#s0003}
------------------------

Adult male SD rats (280 ± 40 g), were purchased from the SJA Lab Animal Center of Changsha (Changsha, PR China). All animals were bred in sub-cages in a clean grade laboratory environment in a constant temperature condition (23 ± 1 °C), and accepted 12 h artificial lighting for acclimatization. All rats freely consumed water and food. After one week, the 52 experimental rats were divided into four groups (*n* = 13): control group (normal rats), DM group (diabetes rats), DM + NaHS group (diabetes rats treated with NaHS), and NaHS group (normal rats treated with NaHS). Diabetes was induced by a single intraperitoneal injection of 40 mg/kg STZ (MP Biomedicals LLC, Santa Ana, CA), which was dissolved quickly in 0.1 mol/L sodium citrate buffer 72 h after STZ injection.

Only those rats with a blood glucose level ≥16.7 mmol/L were considered as successful diabetic models. The rats accepting the injection were administered 5% glucose water within 24 h to prevent hypoglycemia shock.

A total of 12 rats were sacrificed before and after modeling, and concentrated in the two weeks after modeling. The overall survival rate of rats was 77% (40/52). In the control group, DM group, DM + NaHS group, and NaHS group, the numbers of successful survival models were 12, 9, 9, and 10, respectively. Rats' mental state in the control group was good and responsive, maintaining white and shiny coats. While diabetic rats showed polydipsia, polyphagia, polyuria, and weight loss and some other symptoms like unresponsiveness and dull fur. After the modeling, DM + NaHS group and NaHS group accepted intraperitoneal injection of NaHS solution at a dose of 100 μmol/kg daily, while the control group and DM group were injected intraperitoneally the same dose of NS daily for eight weeks. This study was approved by the Animal Care Committee of the University of South China and conformed to the Guide for the Care and Use of Laboratory Animals.

Blood sample and tissue collection {#s0004}
----------------------------------

After eight weeks, all rats were sacrificed by intraperitoneal injection of chloral hydrate (350 mg/kg). Then the rats' thoracic cavities were opened and were perfused intracardially with NS and fixative 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The kidney of each rat was removed and fixed in the same fixative for 12 h and then placed in 30% phosphate-buffered sucrose until the tissue sank.

Histopathological examination and immunohistochemical assay {#s0005}
-----------------------------------------------------------

Kidneys were fixed in 4% paraformaldehyde and were embedded in paraffin, sectioned and stained with Masson staining, and at last observed at ×400 magnification under optical microscope. The expressions of collagen I and III were determined by immunohistochemistry. Slides were deparaffinized in xylene and hydrated in ethanol gradient. The tissue sections, treated with 3% hydrogen peroxide (H~2~O~2~) solution for 15 min, were washed with phosphate buffered saline (PBS) three times at room temperature. The antigen was recovered by boiling for 15 min in tris-ethylenediaminetetraacetic acid buffer in microwave oven at high power. After cooling, the slides were washed for three times in PBS. Then, primary antibody was incubated for 1 h at 37 °C. These sections were washed and incubated with horseradish peroxidase (HRP)-labeled goat anti-rabbit/mouse polyclonal antibodies at 37 °C for 10 min, and 3,3 diaminobenzidine (DAB) was used for color reaction. The reaction was washed with distilled water twice before stopped, and then stained with hematoxylin.

Specimen collection and processing {#s0006}
----------------------------------

At the end of the eight weeks, 24 h urinary protein (Ualb) and 24 h urinary microalbumin excretion were determined by biochemical methods.

Hydroxyproline content assay {#s0007}
----------------------------

Kidney hydroxyproline content was measured by basic hydrolysis method with a hydroxyproline detection kit (Nanjing Jiancheng Bioengineering Institute, Nanjing Shi, PR China). The 10 mg pieces of tissue was mixed with HCl and added to 1 ml basic hydrolysates in oven at 120 °C overnight. Then, the hydrolysates were neutralized and mixed with chloramine T solution and oxidized for 20 min at room temperature. The oxidized product reacted with p-dimethylaminobenzaldehyde in ethanol and H~2~SO~4~ solution at 60 °C for about 25 min. And the resulting chromophore was quantified spectrophotometrically at 557 nm against a standard curve of known hydroxyproline concentration.

Western blot analysis {#s0008}
---------------------

A frozen kidney tissue of rats in each group was taken to extract proteins and estimate the protein by bicinchoninic acid assay (BCA) colorimetric method. The protein was denatured and separated by SDS-PAGE electrophoretic technique and transferred to a polyvinylidene difluoride (PVDF) membrane. After formulating with 5% bovine serum albumin (BSA) for 2 h, the blocked membranes were incubated with ERK1/2 (cell signaling), TGF-β1, MMP-2, MMP-7, MMP-8, MMP-11, MMP-14, TIMP1, and TIMP2 (Boster Biological Technology, Ltd., Wuhan, PR China) antibody, and then washed with tris buffered saline with Tween (TBST), and detected with a secondary antibodies (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD), and finally these membranes were subjected to chemiluminescence detection assay.

Statistical analysis {#s0009}
--------------------

SPSS version 18.0 (SPSS Inc., Chicago, IL) was used for statistical analysis. Values are presented as mean ± SD. Statistical differences between the groups were assessed by one-way ANOVA with SPSS version 18.0 software. Difference was considered to be statistically significant if *p*\<.05.

Results {#s0010}
=======

Masson staining of kidney tissues {#s0011}
---------------------------------

See [Figure 1(A)](#F0001){ref-type="fig"} for the normal tissue structures and thickness of the basement membrane in kidneys of the normal group. The part made by dyeing blue showed collagen fiber. We observed that the accumulation of collagen fiber was significantly massive in DM group. And the diabetic renal injury is characterized by mesangial expansion, global sclerosis, interstitial fibrosis, and tubular atrophy ([Figure 1(B)](#F0001){ref-type="fig"}). In the diabetic rats treated with NaHS, the findings of the injury was markedly reduced ([Figure 1(C)](#F0001){ref-type="fig"}). The normal rats that accepted NaHS injection presented the same architecture as the normal group ([Figure 1(D)](#F0001){ref-type="fig"}).

![Masson staining of kidney tissues. (A) A rat in control group, (B) a rat in DM group, (C) a rat in DM + NaHS group, and (D) a rat in NaHS group.](IRNF_A_1257433_F0001_C){#F0001}

Immunohistochemistry study of collagen I and III in the kidney {#s0012}
--------------------------------------------------------------

[Figure 2](#F0002){ref-type="fig"} shows collagen I (up) and III (down) expression in glomerulus of normal rats ([Figure 2(A)](#F0002){ref-type="fig"}) by immunohistochemistry study. The part made by dyeing brown showed collagen fiber. Compared with normal rats, the kidney of DM rats presented significantly higher levels of collagen I and III ([Figure 2(B)](#F0002){ref-type="fig"}).

![Immunohistochemistry study of collagen I (up) and collagen III (down) expression in kidney. (A) A rat in control group, (B) a rat in DM group, (C) a rat in DM + NaHS group, and (D) a rat in NaHS group.](IRNF_A_1257433_F0002_C){#F0002}

However, the levels of collagen I and III were significantly decreased in DM + NaHS group ([Figure 2(C)](#F0002){ref-type="fig"}). The normal rats accepted NaHS injection presented the same as the normal group ([Figure 2(D)](#F0002){ref-type="fig"}).

Effects of H~2~S on 24 h urinary protein and 24 h urinary microalbumin excretion (means ± SD) ([Table 1](#t0001){ref-type="table"}) {#s0013}
-----------------------------------------------------------------------------------------------------------------------------------

At the end of the eight weeks, 24 h Ualb and 24 h urinary microalbumin excretion were detected. As shown in [Table 1](#t0001){ref-type="table"}, compared with the normal group 24 h Ualb and 24 h urinary microalbumin excretion in the DM group were significantly increased (*p*\<.01). Compared with DM group, 24 h Ualb and 24 h urinary microalbumin excretion in the DM rats treated with NaHS showed a marked decrease (*p*\<.01), but it was still higher than the control group.

###### 

Effects of hydrogen sulfide on 24-h urinary protein and 24-h urinary microalbumin excretion (mean ± SD).

  Groups            24-h urinaryprotein excretion                24-h urinarymicroalbuminexcretion
  ----------------- -------------------------------------------- --------------------------------------------
  Control group     11.8 ± 3.3                                   0.5 ± 0.3
  DM group          44.5 ± 6.4[^a^](#TF1){ref-type="table-fn"}   13.0 ± 2.6[^a^](#TF1){ref-type="table-fn"}
  DM + NaHS group   26.6 ± 6.1[^b^](#TF2){ref-type="table-fn"}   5.9 ± 2.4[^b^](#TF2){ref-type="table-fn"}
  NaHS group        12.6 ± 4.0                                   0.6 ± 0.3

*p*\<.01 vs. control group.

*p*\<.01 vs. DM group.

Effects of H~2~S on hydroxyproline content in diabetes rats {#s0014}
-----------------------------------------------------------

Hydroxyproline content in kidney of each group are showed in [Figure 3](#F0003){ref-type="fig"}. Compared with control group, there was a significantly higher level of hydroxyproline in DM group (*p*\<.01). However, compared with DM group, it decreased remarkably in DM + NaHS group (*p*\<.01).

![Hydroxyproline content in kidney of each group.](IRNF_A_1257433_F0003_B){#F0003}

Effects of H~2~S on TGF-β1 and ERK1/2 expressions in diabetes rats {#s0015}
------------------------------------------------------------------

As showed in [Figure 4](#F0004){ref-type="fig"} TGF-β1 and ERK1/2 expressions in DM group were much higher than those in the control group (*p*\<.01). However, compared with DM group, TGF-β1 and ERK1/2 expressions were markedly decreased in DM + NaHS group (*p* \< .01).

![TGF-β1 (A) and ERK1/2 (B) expression in the renal tissues from each group (normalized by GAPDH).](IRNF_A_1257433_F0004_B){#F0004}

TIMP1 and TIMP2 expressions in each group {#s0016}
-----------------------------------------

As showed in [Figure 5](#F0005){ref-type="fig"}, TIMP1 (*p* \< .05) and TIMP2 (*p* \< .01) expressions in DM group were much higher than those in the control group. While, compared with DM group, TIMP1 and TIMP2 expressions were significantly decreased in DM + NaHS group (*p* \< .01), and TIMP1 expression was decreased in DM + NaHS group (*p* \>.05).

![TIMP1 and TIMP2 expressions in the renal tissues from each group \[normalized by glyceraldehyde-3-phosphate dehydrogenase (GAPDH)\].](IRNF_A_1257433_F0005_C){#F0005}

MMP-2, MMP-7, MMP-8, MMP-11, and MMP-14 expression in each group {#s0017}
----------------------------------------------------------------

As showed in [Figure 6](#F0006){ref-type="fig"}, there was MMP-2, MMP-7, MMP-8, MMP-11, and MMP-14 expression were much higher than those in DM group (*p* \< .01).

![Expression of MMP-2, MMP-7, MMP-8, MMP-11, MMP-14 in the renal tissues from each group (normalized by GAPDH).](IRNF_A_1257433_F0006_C){#F0006}

While, compared with DM group, MMP-2, MMP-7, MMP-8, MMP-11, and MMP-14 expression were significantly decreased in DM + NaHS group (*p* \< .01).

Discussion {#s0018}
==========

Renal fibrosis is a common consequence of chronic renal disease such as DN, which may finally give rise to severe clinical complications and dysfunction. The histological features of renal fibrosis are excessive deposition of ECM and interstitial fibroblast. While, the typical pathological change of DN is glomerular sclerosis followed by thickening of renal tubule and glomerulus basement membrane, mesangial ECM expansion, hypernephrotrophy and renal tubule interstitial fibrosis.[@CIT0011]^,^[@CIT0012] While, MMPs, inhibited by tissue inhibitors of MMPs (TIMPs), are responsible for the degradation of ECM, and their substrates contain collagens, proteoglycans and many glycoproteins. MMP-7, a member of the MMP family, can cleave a series of substrates including collagen, fibronectin, and is largely regulated by TIMP2.[@CIT0013] MMP-8 is deemed as neutral neutrophil collagenase mainly secreted by neutrophils. In condition of inflammation and wound healing process, the common expression of MMP-8 was significantly increased. Activated MMP-8 can decrease collagen matrix and damage its structure, giving rise to the expression of fibrosis and high expression of collagen I and III.[@CIT0014]^,^[@CIT0015] MMP-14 is a transmembrane protein, and MMP-11 can be soluble in cellular microenvironment. MMP-11 is a substrate of MMP-14, and it is able to prevent MMP-11 enzymatic activity. By hydrolyzing MMP-11, MMP-14 can provide space for restrictions and protease activity of MMP-11, and protections for specific and important cells surrounding ECM from MMP-11 in an inappropriate correlation. MMP-14, a membrane-bound metalloproteinase, is processed before its insertion into specific plasma membrane domains.[@CIT0016] The major functions of MMP-14 include the degradation of some certain ECM components and the activation of proMMP-2,[@CIT0017] which then decreases collagen IV, the primary component of the basement membrane.[@CIT0018] TIMP2 combines either the active or latent form of MMP-2 with less inhibitory activity to other MMPs.[@CIT0019] In our study, we found an obvious increase of dark stained collagenous fiber elements of ECM in renal interstitium of diabetic rats and an increase of collagen II in renal glomerulus and tubule interstitial. And there was a higher level of hydroxyproline in DN tissues. Meanwhile, the expressions of TIMP1, TIMP2, MMP-2, MMP-7, MMP-8, MMP-11, and MMP-14, which were publicly involved in the progress of renal fibrosis, were significantly increasing in diabetic rats. All these findings suggest apparent fibrosis of renal interstitium in diabetic rats and its relevance with the reduced degradation of metalloproteinases.

TGF-β family members play a crucial role in homeostasis of adult tissues.

A number of evidences demonstrate that lack of coordination of TGF-β-dependent signalings may result in some diseases such as fibrosis.[@CIT0020] TGF-β1, as an important member of TGF-β family, is an acknowledged mediator in the triggering and progression of fibrosis and has been regarded as the key of ECM expression.[@CIT0021]^,^[@CIT0022] TGF-β1 has been described to be correlated with regulation of the expression and activity of some MMPs/TIMPs in different ways.[@CIT0023] However, downstream TGF-β1 signaling occurs through canonical and non-canonical pathways. ERK1/2, which may be activated in MCs exposed to high glucose, acts as the downstream of TGF-β1 through the non-canonical pathways.[@CIT0024] According to researches based on diabetic animal models, disruption of TGF-β1 signaling significantly attenuated glomerular mesangial matrix expansion.[@CIT0025] TGF-β1 intervention can increase the degree of phosphorylated forms of ERK1/2.[@CIT0026] Studies show that, by inhibiting TGF-β1 protein expression, NaHS failed to decrease the expression of fibronectin compared to the group treated with NaHS without the inhibitors.[@CIT0027] Also, previous studies have demonstrated that MMP-2 can be up-regulated by some stimuli such as TGF-β1, which in turn can activate the fibroblast-to-myofibroblast transition.[@CIT0028] In this study, we verified augmented expression of TGF-β1 and ERK1/2 in the diabetes rats.

Therefore, we demonstrated that TGF-β1 may have a natural link with the pathogenesis of DN by inducing interstitial fibrosis via ERK1/2 pathway. H~2~S, a kind of new gaseous signal, has been suggested to play a variety of necessary physiological and physiopathological roles.[@CIT0029] It is generated from L-cysteine by several enzymes including cystathionine γ lyase (CSE) and cystathionine β synthase (CBS). Some studies have shown that H~2~S biosynthesis is impaired in diabetes, and that it may be effective to administer different H~2~S donors to diabetic animals.[@CIT0030]

In this research, contrasted with DM group, we noted that the expression of collagen fibers in basement membrane and collagen II was distinctly decreased in DM + NaHS group. And 24 h Ualb and 24 h urinary microalbumin excretion were both decreased in DM + NaHS group. Meanwhile, the renal hydroxyproline of DM + NaHS group was markedly decreased. The expression levels of proteins, such as TGF-β1, ERK1/2, TIMP1, TIMP2, MMP-2, MMP-7, MMP-8, MMP-11, and MMP-14 in renal tissues, were up-regulated significantly in the DM group, while the expressions of TGF-β1 and ERK1/2 protein were down-regulated in the DM + NaHS group, and the expressions of TIMP1, TIMP2, MMP-2, MMP-7, MMP-8, MMP-11, and MMP-14 also degraded notably. These all suggested that the mechanism by which H~2~S improves renal tissue fibrosis. In summary, this study demonstrated that treatment with H~2~S could attenuate the progression of renal dysfunction in diabetic rats. The protective effect of H~2~S may be correlated with TGF-β1 signaling through ERK1/2 pathway. However, this proposed mechanism and its clinical prospect in DN protection still need further investigation in the future.
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